Cargando…

Plasma pharmacokinetic profile of fluralaner (Bravecto™) and ivermectin following concurrent administration to dogs

BACKGROUND: Fluralaner is a novel systemic ectoparasiticide for dogs providing immediate and persistent flea, tick and mite control after a single oral dose. Ivermectin has been used in dogs for heartworm prevention and at off label doses for mite and worm infestations. Ivermectin pharmacokinetics c...

Descripción completa

Detalles Bibliográficos
Autores principales:	Walther, Feli M., Allan, Mark J., Roepke, Rainer KA
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Short Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4595236/ https://www.ncbi.nlm.nih.gov/pubmed/26438338 http://dx.doi.org/10.1186/s13071-015-1123-8

Ejemplares similares

Safety of concurrent treatment of dogs with fluralaner (Bravecto™) and milbemycin oxime - praziquantel
por: Walther, Feli M, et al.
Publicado: (2014)

Safety of the concurrent treatment of dogs with Bravecto™ (fluralaner) and Scalibor™ protectorband (deltamethrin)
por: Walther, Feli M, et al.
Publicado: (2014)

Safety of fluralaner chewable tablets (Bravecto(TM)), a novel systemic antiparasitic drug, in dogs after oral administration
por: Walther, Feli M, et al.
Publicado: (2014)

The effect of food on the pharmacokinetics of oral fluralaner in dogs
por: Walther, Feli M, et al.
Publicado: (2014)

Safety of topical administration of fluralaner plus moxidectin concurrently with praziquantel in cats
por: Walther, Feli M., et al.
Publicado: (2018)

Safety of concurrent treatment of cats with fluralaner and emodepsid–praziquantel
por: Walther, Feli M., et al.
Publicado: (2016)

Onset of activity of fluralaner (BRAVECTO™) against Ctenocephalides felis on dogs
por: Taenzler, Janina, et al.
Publicado: (2014)

The speed of kill of fluralaner (Bravecto™) against Ixodes ricinus ticks on dogs
por: Wengenmayer, Christina, et al.
Publicado: (2014)

Erratum to: Safety of concurrent treatment of cats with fluralaner and emodepsid-praziquantel
por: Walther, Feli M., et al.
Publicado: (2016)

Comparative pharmacokinetics of fluralaner in dogs and cats following single topical or intravenous administration
por: Kilp, Susanne, et al.
Publicado: (2016)

Pharmacokinetics of fluralaner in dogs following a single oral or intravenous administration
por: Kilp, Susanne, et al.
Publicado: (2014)

Prevention of transmission of Babesia canis by Dermacentor reticulatus ticks to dogs treated orally with fluralaner chewable tablets (Bravecto™)
por: Taenzler, Janina, et al.
Publicado: (2015)

Safety of fluralaner, a novel systemic antiparasitic drug, in MDR1(-/-) Collies after oral administration
por: Walther, Feli M, et al.
Publicado: (2014)

A randomized, blinded, controlled and multi-centered field study comparing the efficacy and safety of Bravecto™ (fluralaner) against Frontline™ (fipronil) in flea- and tick-infested dogs
por: Rohdich, Nadja, et al.
Publicado: (2014)

A European field assessment of the efficacy of fluralaner (Bravecto(®)) chewable and spot-on formulations for treatment of dogs with generalized demodicosis
por: Petersen, Ivo, et al.
Publicado: (2020)

A quantitative evaluation of the extent of fluralaner uptake by ticks (Ixodes ricinus, Ixodes scapularis) in fluralaner (Bravecto(TM)) treated vs. untreated dogs using the parameters tick weight and coxal index
por: Williams, Heike, et al.
Publicado: (2015)

Efficacy of orally and topically administered fluralaner (Bravecto(®)) for treatment of client-owned dogs with sarcoptic mange under field conditions
por: Chiummo, Rafael, et al.
Publicado: (2020)

Treatment of dogs with Bravecto(®) (fluralaner) reduces mosquito survival and fecundity
por: Evans, Christopher Charles, et al.
Publicado: (2023)

Efficacy of fluralaner plus moxidectin (Bravecto® Plus spot-on solution for cats) against Otodectes cynotis infestations in cats
por: Taenzler, Janina, et al.
Publicado: (2018)

Prevention of transmission of Babesia canis by Dermacentor reticulatus ticks to dogs after topical administration of fluralaner spot-on solution
por: Taenzler, Janina, et al.
Publicado: (2016)

Suspected neurological toxicity after oral application of fluralaner (Bravecto®) in a Kooikerhondje dog
por: Gaens, Daniela, et al.
Publicado: (2019)

Efficacy of fluralaner (Bravecto™ chewable tablets) for the treatment of naturally acquired Linognathus setosus infestations on dogs
por: Kohler-Aanesen, Heike, et al.
Publicado: (2017)

Fluralaner (Bravecto(®)) treatment kills Aedes aegypti after feeding on Dirofilaria immitis-infected dogs
por: Duncan, Kathryn, et al.
Publicado: (2023)

Comparative speed of kill of sarolaner (Simparica(™)) and fluralaner (Bravecto(®)) against induced infestations of Ctenocephalides felis on dogs
por: Six, Robert H., et al.
Publicado: (2016)

Efficacy of fluralaner chewable tablets (Bravecto(®)) against Asian longhorned tick (Haemaphysalis longicornis) infestations of dogs
por: Petersen, Melissa, et al.
Publicado: (2023)

Efficacy of two topical fluralaner formulations (Bravecto®; Bravecto® Plus) against Asian longhorned tick (Haemaphysalis longicornis) infestations of cats
por: Petersen, Melissa, et al.
Publicado: (2023)

Comparative speed of kill of sarolaner (Simparica™ Chewables) and fluralaner (Bravecto(®)) against induced infestations of Amblyomma americanum on dogs
por: Six, Robert H., et al.
Publicado: (2016)

Fluralaner (Bravecto®) induces long-term mortality of Lutzomyia longipalpis after a blood meal in treated dogs
por: Queiroga, Tamyres Bernadete Dantas, et al.
Publicado: (2020)

Investigation of the efficacy of fluralaner spot-on (Bravecto®) against infestations of Ixodes holocyclus on cats
por: Fisara, Petr, et al.
Publicado: (2018)

Efficacy of Bravecto(®) Plus spot-on solution for cats (280 mg/ml fluralaner and 14 mg/ml moxidectin) for the prevention of aelurostrongylosis in experimentally infected cats
por: Raue, Katharina, et al.
Publicado: (2021)

Efficacy of orally administered fluralaner (Bravecto(TM)) or topically applied imidacloprid/moxidectin (Advocate®) against generalized demodicosis in dogs
por: Fourie, Josephus J, et al.
Publicado: (2015)

Field efficacy of fluralaner (Bravecto(®) chewable tablets) for preventing Babesia canis infection transmitted by Dermacentor reticulatus ticks to dogs
por: Chiummo, Rafael, et al.
Publicado: (2023)

Publisher Correction: Efficacy of two topical fluralaner formulations (Bravecto®; Bravecto® Plus) against Asian longhorned tick (Haemaphysalis longicornis) infestations of cats
por: Petersen, Melissa, et al.
Publicado: (2023)

Efficacy of fluralaner against Otodectes cynotis infestations in dogs and cats
por: Taenzler, Janina, et al.
Publicado: (2017)

A single oral dose of fluralaner (Bravecto®) in dogs rapidly kills 100% of blood‐fed Phlebotomus perniciosus, a main visceral leishmaniasis vector, for at least 1 month after treatment
por: Bongiorno, G., et al.
Publicado: (2019)

Efficacy of fluralaner flavored chews (Bravecto®) administered to dogs against the adult cat flea, Ctenocephalides felis felis and egg production
por: Dryden, Michael W, et al.
Publicado: (2015)

Comparative speed of kill of oral treatments with Simparica(TM)(sarolaner) and Bravecto®(fluralaner) against induced infestations of Rhipicephalus sanguineus on dogs
por: Becskei, Csilla, et al.
Publicado: (2016)

Field effectiveness and safety of fluralaner plus moxidectin (Bravecto® Plus) against ticks and fleas: a European randomized, blinded, multicenter field study in naturally-infested client-owned cats
por: Rohdich, Nadja, et al.
Publicado: (2018)

A randomized, blinded, controlled, multi-centered field study assessing the treatment of gastrointestinal nematode infections in cats with fluralaner plus moxidectin spot-on solution (Bravecto® Plus)
por: Rohdich, Nadja, et al.
Publicado: (2018)

Erratum to: Efficacy of fluralaner flavored chews (Bravecto®) administered to dogs against the adult cat flea, Ctenocephalides felis felis and egg production
por: Dryden, Michael W., et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_t7d6tdfrps3il2ahe65ktn422j